Ion Exchange (india) Ltd. · NSE:IONEXCHANG
Ion Exchange (india) — Q3 FY2025 Earnings Presentation
24 slides from Ion Exchange (india)'s earnings presentation, Jan 24, 2025
Slide 1: Submission of Analyst / Investor Presentation to exchanges
January 24, 2025 To BSE Limited National Stock Exchange of India Limited The Corporate Relationship Dept. Exchange Plaza, C-1, Block- G, P.J. Towers, Dalal Street Bandra Kurla Complex, Bandra (East), Mumbai-400 001 Mumbai-400 051 Scrip Code: 500214 Scrip Code: IONEXCHANG Sub: Submission of Analyst /
Slide 2: Earnings Presentation – Q3 / 9M-FY25
EARNINGS PRESENTATION – Q3 / 9M-FY25
Slide 3: Executive Summary
Executive Summary • Ion Exchange (India) Ltd (Ion Exchange), formed in 1964, is a pioneer in water, wastewater treatment & environment solutions and caters to various industries, institutions, homes & communities. • Headquartered in Mumbai, the company has 7 manufacturing and assembly facilities acr
Slide 4: Company Overview
Company Overview • Ion Exchange was originally formed as a subsidiary of Permutit, UK in 1964. It became a wholly owned FY24 CONSOLIDATED REVENUE BREAKUP* Indian company in 1985. The company is currently in its 60th Year of operations. • The company has expanded its footprints globally and possesses
Slide 5: Q3 / 9M-FY25 Financial Highlights
Q3 / 9M-FY25 Financial Highlights Q3-FY25 Performance (Standalone) Q3-FY25 Performance (Consolidated) INR 6,499 Mn INR 744 Mn 11.45% 10.92% INR 6,905 Mn INR 754 Mn Operating Income Operating EBITDA Operating EBITDA Operating EBITDA Operating Income Operating EBITDA Margins Margins INR 533 Mn 8.20% I
Slide 6: Q3 / 9M-FY25 Operational Highlights
Q3 / 9M-FY25 Operational Highlights ENGINEERING • Increase in turnover largely due to improved execution of some of the large EPC contracts. However, the UP Jal Nigam contract execution was muted. • Modest order flow during the quarter. • The domestic enquiry bank remains steady. CHEMICALS • The seg
Slide 7: Financial Overview
FINANCIAL OVERVIEW,
Slide 8: Quarterly Standalone Financial Performance
Quarterly Standalone Financial Performance INCOME STATEMENT (INR MN) Q3-FY25 Q3-FY24 Y-o-Y Q2-FY25 Q-o-Q Operating Income 6,499 5,124 26.8% 5,889 10.4% Expenses 5,755 4,434 29.8% 5,219 10.3% Operating EBITDA 744 690 7.8% 670 11.0% Operating EBITDA Margins (%) 11.45% 13.47% (202) Bps 11.38% 7 Bps Dep
Slide 9: Quarterly Standalone Segmental Breakup
Quarterly Standalone Segmental Breakup ENGINEERING (INR MN) CHEMICALS (INR MN) CONSUMER PRODUCTS (INR MN) R 4,173 E 3,068 V 1,601 1,715 E 772 630 N U E Q3-FY24 Q3-FY25 Q3-FY24 Q3-FY25 Q3-FY24 Q3-FY25 Q3-FY24 Q3-FY25 499 454 E 269 284 B I T (16) Q3-FY24 Q3-FY25 Q3-FY24 Q3-FY25 (31) 8
Slide 10: YTD Standalone Financial Performance
YTD Standalone Financial Performance INCOME STATEMENT (INR MN) 9M-FY25 9M-FY24 Y-o-Y Operating Income 17,550 14,454 21.4% Expenses 15,530 12,660 22.7% Operating EBITDA 2,020 1,794 12.6% Operating EBITDA Margins (%) 11.51% 12.41% (90) Bps Depreciation 293 239 22.6% Finance Cost 59 55 7.3% Other Incom
Slide 11: YTD Standalone Segmental Breakup
YTD Standalone Segmental Breakup ENGINEERING (INR MN) CHEMICALS (INR MN) CONSUMER PRODUCTS (INR MN) R 11,010 E 8,714 4,955 V 4,396 E 2,123 1,809 N U E 9M-FY24 9M-FY25 9M-FY24 9M-FY25 9M-FY24 9M-FY25 9M-FY24 9M-FY25 1,413 1,194 E 670 741 B (35) I T 9M-FY24 9M-FY25 9M-FY24 9M-FY25 (101) 10
Slide 12: Quarterly Consolidated Financial Performance
Quarterly Consolidated Financial Performance INCOME STATEMENT (INR MN) Q3-FY25 Q3-FY24 Y-o-Y Q2-FY25 Q-o-Q Operating Income 6,905 5,539 24.7% 6,445 7.1% Expenses 6,151 4,833 27.3% 5,763 6.7% Operating EBITDA 754 706 6.8% 682 10.6% Operating EBITDA Margins (%) 10.92% 12.75% (183) Bps 10.58% 34 Bps De
Slide 13: Quarterly Consolidated Segmental Breakup
Quarterly Consolidated Segmental Breakup ENGINEERING (INR MN) CHEMICALS (INR MN) CONSUMER PRODUCTS (INR MN) 4,301 R E 3,212 1,872 1,993 772 V 630 E N U E Q3-FY24 Q3-FY25 Q3-FY24 Q3-FY25 Q3-FY24 Q3-FY25 523 Q3-FY24 Q3-FY25 493 E 257 240 B I (15) T Q3-FY24 Q3-FY25 (29) Q3-FY24 Q4-FY25 12
Slide 14: YTD Consolidated Financial Performance
YTD Consolidated Financial Performance INCOME STATEMENT (INR MN) 9M-FY25 9M-FY24 Y-o-Y Operating Income 19,026 15,660 21.5% Expenses 16,946 13,862 22.2% Operating EBITDA 2,080 1,798 15.7% Operating EBITDA Margins (%) 10.93% 11.48% (55) Bps Depreciation 327 260 25.8% Finance Cost 99 88 12.5% Other In
Slide 15: YTD Consolidated Segmental Breakup
YTD Consolidated Segmental Breakup ENGINEERING (INR MN) CHEMICALS (INR MN) CONSUMER PRODUCTS (INR MN) R 11,485 5,956 E 5,095 9,222 V 2,123 1,809 E N U E 9M-FY24 9M-FY25 9M-FY24 9M-FY25 9M-FY24 9M-FY25 9M-FY24 9M-FY25 1,543 1,282 679 E 582 B (32) I T 9M-FY24 9M-FY25 9M-FY24 9M-FY25 (98) 14
Slide 16: Historical Financial Overview
HISTORICAL FINANCIAL OVERVIEW
Slide 17: Historical Standalone Financial Performance
Historical Standalone Financial Performance INCOME STATEMENT (INR MN) FY21 FY22 FY23 FY24 9M-FY25 Operating Income 14,018 15,094 18,923 21,800 17,550 Expenses 12,067 13,123 16,544 19,129 15,530 Operating EBITDA 1,951 1,971 2,379 2,671 2,020 Operating EBITDA Margins (%) 13.92% 13.06% 12.57% 12.25% 11
Slide 18: Historical Standalone Balance Sheet
Historical Standalone Balance Sheet PARTICULARS (INR MN) FY23 FY24 H1-FY25 PARTICULARS (INR MN) FY23 FY24 H1-FY25 EQUITIES & LIABILITIES ASSETS Equity Non-Current Assets (A) Property, Plant and Equipment 1,680 2,149 2,175 (A) Equity Share Capital 147 147 147 (B) Capital Work-in-progress 420 607 1,33
Slide 19: Historical Consolidated Financial Performance
Historical Consolidated Financial Performance INCOME STATEMENT (INR MN) FY21 FY22 FY23 FY24 9M-FY25 Operating Income 14,495 15,769 19,896 23,479 19,026 Expenses 12,472 13,637 17,346 20,759 16,946 Operating EBITDA 2,023 2,132 2,550 2,720 2,080 Operating EBITDA Margins (%) 13.96% 13.52% 12.82% 11.58%
Slide 20: Historical Consolidated Balance Sheet
Historical Consolidated Balance Sheet PARTICULARS (INR MN) FY23 FY24 H1-FY25 PARTICULARS (INR MN) FY23 FY24 H1-FY25 EQUITIES & LIABILITIES ASSETS Equity Non-Current Assets (A) Equity Share Capital 142 142 142 (A) Property, Plant and Equipment 1,707 3,018 3,062 (B) Other Equity 8,193 10,037 10,818 (B
Slide 21: Consolidated Financial Performance
Consolidated Financial Performance REVENUES (INR MN) OPERATING EBITDA (INR MN) PAT (INR MN) 2,720 23,479 2,550 19,896 2,023 2,132 1,950 1,954 17,550 2,020 15,769 1,433 1,617 1,499 14,495 11.51% 8.54% 13.96% 13.52% 12.82% 9.89% 10.25% 9.80% 11.58% 8.32% FY21 FY22 FY23 FY24 9M-FY25 FY21 FY22 FY23 FY24
Slide 22: Market Data (Bloomberg – ION IN, Reuters – IONX.BO)
Market Data (Bloomberg – ION IN, Reuters – IONX.BO) 1 YEAR SHARE PRICE MOVEMENT (UP TO 31st December 2024) 40% 30% 20% 10% 0% -10% -20% -30% Jan-24 Feb-24 Mar-24 Apr-24 May-24 Jun-24 Jul-24 Aug-24 Sep-24 Oct-24 Nov-24 Dec-24 Ion Exchange Sensex PRICE DATA (As on 31st December 2024) SHAREHOLDING PATT
Slide 23: Disclaimer
Disclaimer Ion Exchange (India) Limited No representation or warranty, express or implied, is made as to, and no reliance should be placed on, the fairness, accuracy, completeness or correctness of the information or opinions contained in this presentation. Such information and opinions are in all e
Slide 24: Thank You
THANK YOU
Ion Exchange (India) — Q3 FY2025 Earnings Presentation on 6ix